Johnson & Johnson news and information

Johnson & Johnson reported better-than-expected third-quarter results, as strong growth for prescription drugs overshadowed weaker contributions from its medical device and consumer products businesses.
FULL STORY »

Johnson & Johnson recalled another product Wednesday, pulling some vials of its antipsychotic treatment Risperdal Consta after discovering mold during routine quality testing.
FULL STORY »

The Food and Drug Administration is requiring stronger warning labels on prescription painkillers like OxyContin, in the government's latest attempt to reduce overdose deaths caused by the long-acting medications.
FULL STORY »

Johnson & Johnson is recalling 200,000 bottles of Motrin Infants formula due to the risk that they contain tiny plastic particles.
FULL STORY »

Like insurance company executives, the leaders of big healthcare vendors, supply companies and group purchasing organizations are seeing their roles and the nature of their influence changing. And, naturally, the bigger the organization, the bigger their influence.
FULL STORY »

Johnson & Johnson, the world's biggest seller of healthcare products, has discussed paying more than $3 billion to settle lawsuits over its recalled hip implants, according to five people familiar with the matter.
FULL STORY »

Healthcare giant Johnson & Johnson says it is pleased to put a legal dispute behind it after a Chinese court ordered it to pay compensation to a former distributor under an anti-monopoly law.
FULL STORY »

Reprocessing single-use medical devices is not new. The practice has been around for decades, but the market has reported significant growth as more hospitals seek to save money and reduce waste.
FULL STORY »

Johnson & Johnson said it would pay up to $1 billion for Aragon Pharmaceuticals and its experimental drugs for prostate cancer, to bolster J&J's role in the field after it acquired another experimental prostate-cancer treatment four years ago that has become a leading brand.
FULL STORY »

The Centers for Disease Control and Prevention hinted at promising news on the obesity front last week. The CDC's annual survey of the health status of Americans revealed obesity rose in 2012 at its slowest pace in a decade and, statistically speaking, may not have risen at all. Some experts said...
FULL STORY »